These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21091671)

  • 41. [Effects of drugs known to trigger psoriasis on HaCaT keratinocytes].
    Cen JP; Zhu KJ; Jin N; Lin AH; Cheng H
    Yao Xue Xue Bao; 2007 Oct; 42(10):1041-4. PubMed ID: 18229608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence that the immunopathogenic mechanism of lithium-induced psoriasis differs from that of regular psoriasis.
    Knijff EM; Kupka RW; Ruwhof C; Breunis MN; Prens EP; Nolen WA; Drexhage HA
    Bipolar Disord; 2005 Aug; 7(4):388-9. PubMed ID: 16026493
    [No Abstract]   [Full Text] [Related]  

  • 43. [Drug eruptions caused by lithium salts].
    Lambert D; Beylot C; Mazet J; Verret JL; Delperon C; Weber M
    Ann Med Interne (Paris); 1984; 135(8):637-8. PubMed ID: 6241439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers.
    Goiriz R; Daudén E; Pérez-Gala S; Guhl G; García-Díez A
    Clin Exp Dermatol; 2007 Mar; 32(2):176-9. PubMed ID: 17176269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Correlations between beta blockers and the induction of psoriasis].
    Altomare GF; Gandossi E; Pigatto PD; Polenghi MM
    G Ital Dermatol Venereol; 1987 Oct; 122(10):531-3. PubMed ID: 2895063
    [No Abstract]   [Full Text] [Related]  

  • 46. [The dangers of the sudden discontinuation of drugs].
    de Graeff PA
    Ned Tijdschr Geneeskd; 1985 Jun; 129(22):1034-9. PubMed ID: 2861575
    [No Abstract]   [Full Text] [Related]  

  • 47. [Severe psoriasis induced by chloroquine (nivaquine)].
    Nicolas JF; Mauduit G; Haond J; Chouvet B; Thivolet J
    Ann Dermatol Venereol; 1988; 115(3):289-93. PubMed ID: 2970239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug interactions in anesthesia.
    Cooke JE
    Clin Plast Surg; 1985 Jan; 12(1):83-9. PubMed ID: 2858281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tranilast could has potential therapeutic value in the treatment of psoriasis.
    Mansouri K; Motlagh HR; Keshavarz M
    Med Hypotheses; 2011 Feb; 76(2):217-9. PubMed ID: 21030156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exacerbation of psoriasis during lithium treatment.
    Skott A; Mobacken H; Starmark JE
    Br J Dermatol; 1977 Apr; 96(4):445-8. PubMed ID: 861183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pustular psoriasis and the Kobner phenomenon caused by allergic contact dermatitis from zinc pyrithione-containing shampoo.
    Jo JH; Jang HS; Ko HC; Kim MB; Oh CK; Kwon YW; Kwon KS
    Contact Dermatitis; 2005 Mar; 52(3):142-4. PubMed ID: 15811028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of xenobiotics in triggering psoriasis.
    Grželj J; Sollner Dolenc M
    Arch Toxicol; 2020 Dec; 94(12):3959-3982. PubMed ID: 32833044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases.
    Lam J; Polifka JE; Dohil MA
    J Am Acad Dermatol; 2008 Aug; 59(2):295-315. PubMed ID: 18410980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from Taiwan.
    Chen YJ; Wu CY; Shen JL; Chen TT; Chang YT
    J Am Acad Dermatol; 2013 Jul; 69(1):25-33. PubMed ID: 23375515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Exacerbation of psoriasis caused by malaria prophylaxis with chloroquine and proguanil].
    Damstra RJ; van Vloten WA
    Ned Tijdschr Geneeskd; 1991 Apr; 135(15):671-3. PubMed ID: 2038384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Report of a patient with lithium-related alopecia and psoriasis.
    Ghadirian AM; Lalinec-Michaud M
    J Clin Psychiatry; 1986 Apr; 47(4):212-3. PubMed ID: 2937775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High prevalence of potential drug-drug interactions for psoriasis patients prescribed methotrexate or cyclosporine for psoriasis: associated clinical and economic outcomes in real-world practice.
    Saurat JH; Guérin A; Yu AP; Latremouille-Viau D; Wu EQ; Gupta SR; Bao Y; Mulani PM
    Dermatology; 2010; 220(2):128-37. PubMed ID: 20130383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-α inhibitor therapy. A study of 16 biopsies.
    Laga AC; Vleugels RA; Qureshi AA; Velazquez EF
    Am J Dermatopathol; 2010 Aug; 32(6):568-73. PubMed ID: 20520526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Exacerbation of psoriasis by lithium carbonate: apropos of a case].
    Seguí Montesinos J; Martín E; Salvador Carulla L
    Med Clin (Barc); 1986 Feb; 86(6):261-2. PubMed ID: 3084892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.